CN1255142A - B－环雌甾三烯二醇硫酸酯 - Google Patents

B－环雌甾三烯二醇硫酸酯 Download PDF

Info

Publication number
CN1255142A
CN1255142A CN98804836A CN98804836A CN1255142A CN 1255142 A CN1255142 A CN 1255142A CN 98804836 A CN98804836 A CN 98804836A CN 98804836 A CN98804836 A CN 98804836A CN 1255142 A CN1255142 A CN 1255142A
Authority
CN
China
Prior art keywords
estratriene
carbon atom
alkyl
glycol
ammonium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98804836A
Other languages
English (en)
Chinese (zh)
Inventor
M·Z·卡甘
P·拉文德拉纳斯
S·M·沙
M·W·温克莱
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of CN1255142A publication Critical patent/CN1255142A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN98804836A 1997-05-05 1998-04-28 B－环雌甾三烯二醇硫酸酯 Pending CN1255142A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84188297A 1997-05-05 1997-05-05
US08/841,882 1997-05-05

Publications (1)

Publication Number Publication Date
CN1255142A true CN1255142A (zh) 2000-05-31

Family

ID=25285939

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98804836A Pending CN1255142A (zh) 1997-05-05 1998-04-28 B－环雌甾三烯二醇硫酸酯

Country Status (16)

Country Link
EP (1) EP0983294B1 (da)
JP (1) JP2001526654A (da)
KR (1) KR20010012274A (da)
CN (1) CN1255142A (da)
AR (1) AR014871A1 (da)
AT (1) ATE230756T1 (da)
AU (1) AU750306B2 (da)
BR (1) BR9809592A (da)
CA (1) CA2289011A1 (da)
DE (1) DE69810617T2 (da)
DK (1) DK0983294T3 (da)
ES (1) ES2187966T3 (da)
PT (1) PT983294E (da)
TW (1) TW464653B (da)
WO (1) WO1998050414A1 (da)
ZA (1) ZA983729B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0208165A (pt) * 2001-03-16 2004-03-30 Wyeth Corp Composições farmacêuticas e seus usos na terapia de reposição de estrogênio

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE635781C (de) * 1934-10-14 1936-10-02 Merck Ag E Verfahren zur Herstellung von Abbauprodukten des Neoergosterins
GB864231A (en) * 1958-08-07 1961-03-29 Glaxo Lab Ltd Improvements in or relating to the preparation of steroids

Also Published As

Publication number Publication date
PT983294E (pt) 2003-04-30
ATE230756T1 (de) 2003-01-15
DE69810617T2 (de) 2003-10-02
TW464653B (en) 2001-11-21
ES2187966T3 (es) 2003-06-16
AU7261198A (en) 1998-11-27
ZA983729B (en) 1999-11-04
CA2289011A1 (en) 1998-11-12
EP0983294B1 (en) 2003-01-08
BR9809592A (pt) 2000-07-04
HK1025577A1 (en) 2000-11-17
DK0983294T3 (da) 2003-02-24
WO1998050414A1 (en) 1998-11-12
KR20010012274A (ko) 2001-02-15
AU750306B2 (en) 2002-07-18
JP2001526654A (ja) 2001-12-18
AR014871A1 (es) 2001-04-11
EP0983294A1 (en) 2000-03-08
DE69810617D1 (de) 2003-02-13

Similar Documents

Publication Publication Date Title
EP0981349B1 (en) 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases
CN1255142A (zh) B－环雌甾三烯二醇硫酸酯
US6693207B2 (en) B-ring estratriene diols
US6713465B1 (en) Pregnanes
EP0980383B1 (en) Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
EP0980381B1 (en) Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders
CN1254343A (zh) 孕甾3,20－二醇一－或二－硫酸酯
CN1259137A (zh) 具有雌激素活性的雌－5(10),7－二烯
HK1025577B (en) B-ring estratriene diol sulphates
JPH10101567A (ja) プロラクチンレベルに対して中立効果を有するエストロゲンの医薬組成物
DE10151114A1 (de) 8ß-Substituierte-11ß-aryl-estra-2,3,5(10)-trienderivate
CN1254342A (zh) 用作孕激素和治疗CNS疾病的5α－孕烷－3β,16α－二醇－20－酮3－硫酸酯的可药用盐
HK1025336B (en) Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
US20010007859A1 (en) Pregnane glucuronides
HK1004376A (en) Use of 8,9-dehydroestrone in estrogen therapy
HK1025514B (en) 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases
HK1025514A (en) 5-alpha-pregnan-3-beta-ol-20-one sulfate for the treatment of tumours and cns diseases

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned
C20 Patent right or utility model deemed to be abandoned or is abandoned